DLBCL

May 19, 2017May 19, 2017

DPX-Survivac to be Tested in Canada as Triple-combo Lymphoma Treatment

News

Patients with a certain type of lymphoma whose tumors are expressing the survivin protein may be able to participate in a Phase 2 Canadian clinical trial of Immunovaccine‘s cancer vaccine DPX-Survivac. ... Read more

July 22, 2016July 22, 2016

Who Gets Chemotherapy for HIV-associated Lymphoma? Depends on Socioeconomic Factors, Study Says

News

Chemotherapy has been shown to prolong the survival of patients with HIV-associated lymphomas, but new data has revealed that not all patients are equally likely to receive chemotherapy. According to ... Read more

May 10, 2016May 10, 2016

Epizyme and LYSA Open Clinical Trial of Combo Therapy for Diffuse Large B-Cell Lymphoma

News

Epizyme, Inc., and the Lymphoma Study Association (LYSA) will jointly investigate the combination of tazemetostat and R-CHOP as a frontline treatment in patients with diffuse large B-cell lymphoma (DLBCL), the most common ... Read more

April 7, 2016April 7, 2016

Researchers Identify MicroRNA as Potential Target in Very Aggressive B-cell Lymphoma

News

Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a potentially new therapeutic target to treat activated B-cell diffuse large B-cell ... Read more

March 23, 2016March 23, 2016

Lymphoma Mutations Seen to Open Four ‘Locks’ on Key Protein to Promote Cancer

News

Researchers at Johns Hopkins have discovered that mutations in lymphoma cells allow these cells to break through four different locks on the protein CARD11, putting the protein in a constantly activated state ... Read more

March 11, 2016March 11, 2016

Milestone Announced in Non-Hodgkin’s Lymphoma Phase 2 Study of Daratumumab

News

Genmab A/S announced that it has reached a $5 million milestone in its collaboration with Janssen Biotech, Inc., in the Phase 2 study of Darzalex (daratumumab) as a potential treatment for non-Hodgkin’s lymphoma (NHL). ... Read more

January 7, 2016January 7, 2016

2 Lymphoma Studies Using CAR T-cell Therapy Report ‘Tremendously Exciting’ Results

News

Presentations at the recent ASH annual meeting reporting novel results from small-scale clinical trials using CAR T-cell technology to treat lymphoma patients were reviewed in very enthusiastic terms by Dr. Marcela Maus, from the Massachusetts General Hospital Cancer Center, ... Read more

January 5, 2016January 5, 2016

Potential B-cell Lymphoma Therapy Given IND Status, Enrolling Patients in Phase 2 Trial

News

Epizyme, Inc., announced that the U.S. Food and Drug Administration’s (FDA) Division of Hematology Products has approved its investigational new drug (IND) application for tazemetostat. The drug was developed to ... Read more

December 29, 2015

Read the Top 10 Lymphoma Articles of 2015

10 – “New Genes for B-cell Lymphoma Revealed” Read full article here: http://bit.ly/1QXtc7g Read Top 10 Lymphoma Articles of 2015: http://bit.ly/1OgWNpU

December 28, 2015December 28, 2015